Abstract:Abstract ObjectiveTo explore the clinical application value of ultrasound elastography (UE) technology in the evaluation of the efficacy of neoadjuvant chemotherapy (NAC) at different time-points in patients with locally advanced breast cancer.MethodsTwo group patients were performed conventional ultrasound and elastography examination before NAC (pre-NAC),after the second (post-2nd-NAC), and the fourth cycles of NAC(post-4th-NAC),including 40 cases of 40 breast cancer patients (age range, 25-72 years) in Strain Elastography (SE) group and 21 cases of 20 breast cancer patients (age range,31-67 years) in shear-wave elastography (SWE) group. Changes in elastographic parameters (elasticity grading and strain ratio in SE group, the maximum elastic value and the average elastic value in SWE group) related to tissue biomechanical properties were then determined and compared to clinical and pathologic tumor response after mastectomy. Receiver operating characteristic (ROC) curve analysis was performed to examine parameters at SE and SWE to predict pathologic response. ResultsThe difference of the SE scores between the effective and the ineffective group were statistically significant, no matter after the second or fourth cycles of NAC(P = 0.003 and P = 0.002).The efficacy of NAC can be evaluated by SE semi-quantitative method（no matter with normal breast tissue or adipose tissue as reference）(with normal breast tissue as reference: area under the receiver operating characteristic curve(AUC): 0.763 (post-2nd-NAC),0.836 (post-4th-NAC) ; sensitivity:66.7% (post-2nd-NAC) , 83.3% (post-4th-NAC); and specificity:87.5% (post-2nd-NAC) , 87.5% (post-4th-NAC)；with adipose tissue as reference area under the receiver operating characteristic curve: 0.733 (post-2nd-NAC) ,0.775 (post-4th-NAC); sensitivity: 66.7% (post-2nd-NAC) ,87.5% (post-4th-NAC); and specificity: 75% (post-2nd-NAC) , 68.7% (post-4th-NAC)) and SWE quantitative parameters(taking Emean as measurement parameter: area under the receiver operating characteristic curve: 0.929 (post-2nd-NAC) ,0.929 (post-4th-NAC); sensitivity:85.7% (post-2nd-NAC), 78.6% (post-4th-NAC); and specificity100% (post-2nd-NAC), 100% (post-4th-NAC);taking Emax as measurement parameter: area under the receiver operating characteristic curve: 0.898 (post-2nd-NAC) , 0.908 (post-4th-NAC); sensitivity: 85.7% (post-2nd-NAC) , 71.4% (post-4th-NAC); and specificity100% (post-2nd-NAC), 100% (post-4th-NAC)) after the second and fourth cycles of NAC. There was no significant statistically difference between SE semi-quantitative methods and SWE quantitative parameters in the evaluation of the efficacy of NAC (P =0.082 post-2nd-NAC and 0.324 (post-4th-NAC)). ConclusionBoth SE and SWE can be potentially used as an early predictor of tumor therapy response in locally advanced breast cancer patients, and there was no significant difference in their assessment effectiveness

Comparative study on ultrasound elastography and MRI for effect evaluation in T1-2N1-2M0 breast cancer neoadjuvant chemotherapy

Evaluation of the T-restaging and Effect after Neoadjuvant Chemotherapy in Advanced Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography

Evaluation on clinical effect of neoadjuvant chemotherapy for breast cancer by contrast-enhanced ultrasound

Value of ultrasonic elasticity score and strain ratio in evaluating breast cancer neoadjuvant chemotherapy

Contrast-enhanced Ultrasonography for Early Prediction of Response of Neoadjuvant Chemotherapy in Breast Cancer

Evaluation of the Response of Breast Cancer Patients to Neoadjuvant Chemotherapy by Combined Contrast-Enhanced Ultrasonography and Ultrasound Elastography

The efficacy of strain elastography and shear-wave elastography in the evaluation of neoadjuvant chemotherapy for patients with locally advanced breast cancer

Accuracy of Preoperative Contrast-enhanced Cone Beam Breast CT in Assessment of Residual Tumor after Neoadjuvant Chemotherapy: A Comparative Study with Breast MRI

Ultrasound Strain Elastography and Contrast-Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer A Nomogram Integrating Ki-67 and Ultrasound Features

Contrast-enhanced Ultrasound for Evaluating the Response of Breast Cancer to Neoadjuvant Chemotherapy: Time-intensity Curve Analysis and Texture Analysis

The evaluation of effectiveness of breast cancer for neoadjuvant chemotherapy with color Doppler ultrasound and ultrasound-guided needle biopsy

Quantitative Contrast-Enhanced Ultrasound Evaluation of Pathological Complete Response in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy

Prediction of Treatment Responses to Neoadjuvant Chemotherapy in Breast Cancer Using Contrast-Enhanced Ultrasound.

Gain Value of 99Tcm-MIBI SPECT/CT Tomography in Evaluating the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer

Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?

Evaluation of Neoadjuvant Chemotherapy Response in Breast Cancer Patients with MRI

Value of ultrasound in predicting pathological complete response of breast cancer after neoadjuvant chemotherapy

Texture Features of Pre-Operative Contrast Enhanced MRI Early Phase Images in Predicting Complete Response for Breast Cancer after Neoadjuvant Chemotherapy

Ultrasound Features Combined with Tumor-Infiltrating Lymphocytes for Prediction of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer.

A Comparison with Magnetic Resonance Imaging

[Value of double contrast-enhanced ultrasound QontraXt three-dimensional pseudocolor quantitative analysis to therapeutic effect evaluation of preoperative neoadjuvant chemotherapy in advanced gastric cancer patients]